Health Care & Life Sciences » Pharmaceuticals | Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
43.54 M
Public Float
-
Intellipharmaceutics International Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.32
Market Cap
$15.4 M
Shares Outstanding
43.54 M
Public Float
-

Profile

Address
30 Worcester Road
Toronto Ontario M9W 5X2
Canada
Employees -
Website http://www.intellipharmaceutics.com
Updated 09/14/2018
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi on October 22, 2009 and is headquartered in Toronto, Canada.

Financials

View All
Created with Highcharts 5.0.14Intellipharmaceutics International Inc.Net Income. Fiscal year is December-November. All values CAD Thousands.11 77611 7764 2304 2309 3759 37513 47113 47111 53711 5372013201420152016201702.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Intellipharmaceutics International Inc.Sales/Revenue. Fiscal year is December-November. All values CAD Thousands.1 5641 5649 6209 6205 1615 1612 9842 9847 1697 1692013201420152016201702.5k5k7.5k10k12.5k

Amina Odidi
President, Chief Operating Officer & Director
Shawn Graham
Independent Director